UB Paderborn / Katalog / Suche / in CDI

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2014-11, Vol.765, p.235-239

2014

Link zum Volltext

Verfügbarkeit prüfen

S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL

HemaSphere, 2023-08, Vol.7 (S3), p.e68516d0-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Working With Veterans and Military Families: An Assessment of Professional Competencies

Professional psychology, research and practice, 2016-02, Vol.47 (1), p.84-92

2016

Link zum Volltext

Verfügbarkeit prüfen

Seawater alkalinity enhancement with magnesium hydroxide and its implication for carbon dioxide removal

Marine chemistry, 2023-06, Vol.253, p.104251, Article 104251

2023

Link zum Volltext

Verfügbarkeit prüfen

Novel Biomarkers and Molecular Targets in ALL

Current hematologic malignancy reports, 2024-02, Vol.19 (1), p.18-34

2024

Link zum Volltext

Verfügbarkeit prüfen

A Content Analysis of Military Psychology: 2002-2014

Military psychology, 2015-11, Vol.27 (6), p.366-375

2015

Link zum Volltext

Verfügbarkeit prüfen

Functional genomic landscape of acute myeloid leukaemia

Nature (London), 2018-10, Vol.562 (7728), p.526-531

2018

Link zum Volltext

Verfügbarkeit prüfen

The Persistence of Minimal Residual Disease in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?

Biology of blood and marrow transplantation, 2016-11, Vol.22 (11), p.1913-1914

2016

Link zum Volltext

Verfügbarkeit prüfen

SOHO State of the Art Updates and Next Questions: Measurable Residual Disease in Acute Lymphoblastic Leukemia - Optimization and Innovation in 2022 and Beyond

Clinical lymphoma, myeloma and leukemia, 2022-12, Vol.22 (12), p.878-882

2022

Link zum Volltext

Verfügbarkeit prüfen

Trial in Progress: A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE ® Antibody Blinatumomab (Blincyto) and Vincristine Sulfate Liposomal Injection (Marqibo) in Adult Subjects with Relapsed/Refractory Philadelphia Negative CD19+ Acute Lymphoblastic Leukemia

Blood, 2021-11, Vol.138 (Supplement 1), p.4404-4404

2021

Link zum Volltext

Verfügbarkeit prüfen

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Cancer cell, 2022-08, Vol.40 (8), p.850-864.e9

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 843

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(779)
Mit Volltextzugriff
(758)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(491)
Life Sciences & Biomedicine
(419)
Humans
(350)
Female
(179)
Male
(160)
Adult
(107)
Animals
(84)
Middle Aged
(82)
Child
(72)
Social Sciences
(72)
Adolescent
(70)
Biological And Medical Sciences
(60)
Immunology
(59)
Aged
(58)
Young Adult
(51)
Science & Technology - Other Topics
(49)
Mice
(46)
Multidisciplinary Sciences
(45)
Psychology
(45)
Mutation
(43)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Progress in adult ALL: incorporation of new agents to frontline treatment

Targeting BCL-2 and ABL/LYN in Philadelphia chromosome-positive acute lymphoblastic leukemia

Concomitant use of a dual Src/ABL kinase inhibitor eliminates the in vitro efficacy of blinatumomab against Ph+ ALL

Reduced Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation for Acute Lymphoblastic Leukemia; Current Evidence, and Improving Outcomes Going Forward

Graft‐versus‐host disease after liver transplantation is associated with bone marrow failure, hemophagocytosis, and DNMT3A mutations

Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent

Outcomes of DA-EPOCH-R induction plus autologous transplant consolidation for double hit lymphoma

Glucose and SIRT2 reciprocally mediate the regulation of keratin 8 by lysine acetylation

Reduced heme levels underlie the exponential growth defect of the Shewanella oneidensis hfq mutant

Comparison and validation of the 2022 European LeukemiaNet guidelines in acute myeloid leukemia

Next-generation sequencing–based MRD in adults with ALL undergoing hematopoietic cell transplantation

Gastrointestinal complications in pediatric lung transplant recipients: Incidence, risk factors, and effects on patient outcomes

Energy determinants GAPDH and NDPK act as genetic modifiers for hepatocyte inclusion formation

Fast beam condition monitor for CMS: Performance and upgrade

S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS IMATINIB IN NEWLY DIAGNOSED PH+ ALL

Working With Veterans and Military Families: An Assessment of Professional Competencies

Seawater alkalinity enhancement with magnesium hydroxide and its implication for carbon dioxide removal

Novel Biomarkers and Molecular Targets in ALL

A Content Analysis of Military Psychology: 2002-2014

Functional genomic landscape of acute myeloid leukaemia

The Persistence of Minimal Residual Disease in Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: We Know It's Bad, Now What?

SOHO State of the Art Updates and Next Questions: Measurable Residual Disease in Acute Lymphoblastic Leukemia - Optimization and Innovation in 2022 and Beyond

Trial in Progress: A Phase 2 Single Arm, Multicenter Trial to Evaluate the Efficacy of the BiTE ® Antibody Blinatumomab (Blincyto) and Vincristine Sulfate Liposomal Injection (Marqibo) in Adult Subjects with Relapsed/Refractory Philadelphia Negative CD19+ Acute Lymphoblastic Leukemia

Venetoclax and Navitoclax in Combination with Chemotherapy in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma

Integrative analysis of drug response and clinical outcome in acute myeloid leukemia

Suchergebnisse filtern